admin – Page 7096 – Get News Story

‘The Adventures of Young Prince Dredge’ by Simon Sien Kang Debuts in Audiobook Format with Narration by Child Actor Finn David

Thus far, the new audiobook version of ‘The Adventures of Young Prince Dredge’ has captivated listeners and earned five-star reviews on Audible

Simon Sien Kang is thrilled to announce the official release of his book ‘The Adventures of Young Prince Dredge’ in an exciting new format. Now, parents, caregivers, and children can listen to this precious tale in audiobook format on Audible with narration by child actor Finn David.

‘The Adventures of Young Prince Dredge’ was created as a prequel to ‘The Mouse and the Princess: Princess Eleanor’s Curse’. This children’s book takes readers on an adventure before Prince Dredge ever crosses paths with Princess Eleanor. In ‘The Adventures of Young Prince Dredge’, embarks on a journey in which he crosses paths with many characters. Some of these characters wish to help him, while others want to hurt Prince Dredge.

Now, ‘The Adventures of Young Prince Dredge’ is available in audiobook format on Audible. Listeners can relax and listen to this 21-minute story narrated by Finn David, a child actor who is known for roles in ‘White Boy Rick’, ‘Guardians of the Galaxy Vol. 3’, and more. He most recently was featured in ‘Drive Away Dolls’ and is slated to star in the in-production film ‘Friday the 13^th: Blood Loss’.

Listeners have thus far left high ratings for ‘The Adventures of Young Prince Dredge’. “The Adventures of Young Prince Dredge is audiobook magic at its finest! The narration is superb, and the story is enchanting. It’s a journey you won’t want to end. Highly recommend for listeners of all ages,” said a recent listener.

Another fan said, “Lose yourself in the blissful world of Prince Dredge! This audiobook is pure magic. The narrator’s voice is mesmerizing, and the story is captivating. A must-listen for anyone who loves a good fantasy!”

The combination of author Sien Kang and narrator David’s creativity bring this story to life for fairy tale, adventure, fantasy fans of all ages. Listeners can now listen to a sample of ‘The Adventures of Young Prince Dredge’ for free and listen to the entire story via Audible subscription by visiting the book’s Audible page.

ABOUT SIMON SIEN KANG

Simon Sien Kang is a children’s book author who has written numerous highly rated titles including ‘The Mouse and the Princess’ series.

Media Contact
Company Name: Simon Kang
Contact Person: Simon Sien Kang
Email: Send Email
Phone: 630-974-7897
Country: United States
Website: https://simonkang.online/

Resilience Resurrected: Mary Antcliff’s ‘The Stone House’ Chronicles a Journey of Hope and Rebirth

In the enchanting pages of “The Stone House” by Mary Antcliff, readers are invited on a captivating journey through the restoration of a house that not only becomes a home but also a symbol of newfound beginnings.

The story unfolds with Missy, the protagonist, witnessing the transformation of a sagging porch roof into a symbol of hope and renewal. The NewTown Brothers Carpenters, a group of skilled and charismatic individuals, take center stage in this heartwarming tale. The camaraderie among the characters, their dedication to the restoration project, and the unexpected twists make “The Stone House” a delightful and engaging read.

As Missy’s new home takes shape, so does the sense of community around her. The NewTown Brothers Carpenters, led by the affable Orv, not only rebuild the physical structure but also provide Missy with a newfound sense of belonging. From the camaraderie on the construction site to the generous offerings of Mama’s kitchen, every detail in the narrative weaves a tapestry of connection and warmth.

The book beautifully explores themes of resilience, friendship, and the power of community. Mary Antcliff’s narrative is rich in detail, painting vivid scenes that transport readers to the heart of the restoration project and the charming village setting. The characters, with their unique personalities and stories, come to life, leaving a lasting impression on readers.

“The Stone House” is not just a tale of construction; it’s a narrative of rebuilding lives, forging connections, and discovering the strength that lies within communities. Antcliff’s storytelling prowess shines through, creating a narrative that is both heartening and thought-provoking.

Readers who enjoy heartwarming stories of community, resilience, and new beginnings will find “The Stone House” to be a delightful and inspiring read.

About The Author

Mary’s first quality that comes to mind is ‘unconditional love’. She is gracious and accepting of all but equally sassy and witty, wise with her counsel if you ask it of her, with humor thrown in as well. She has a unique way of looking at the world. One finds many things in Mary that would be considered extraordinary. She gifts people with music, counseling, speaking, poetry, laughter, safety, and more. She gives grace where it’s needed; forgiveness where forgiveness is required, and joy in the midst of pain. She flourished through abuse and betrayal, picked up the pieces, then healed, protected, and persevered. She is a beautiful child of God.

Book Name: The Stone House: On the Road to Nowhere
Author Name: Mary Antcliff
ISBN Number: 979-8866404667
Ebook Version: Click Here
Paperback Version: Click Here

Media Contact
Company Name: Amazon Publishing Pros
Email: Send Email
Phone: +1-877-992-7638
Country: United States
Website: https://www.amazonpublishingpros.co

Masked rockers, Field of Giants, challenge listeners with new album

Field of Giants, the masked rock band from Oxfordshire, releases their latest album, “The Distance Between Us”. This marks the band’s return after a seven-year hiatus, continuing their legacy of delivering thought provoking music at the forefront of the new wave of Nu Metal. The album is available across all major music platforms through Symphonic Distribution.

“The Distance Between Us” features five awe-inspiring tracks that embody the band’s signature sound: a robust blend of distorted guitars, hard-hitting drums, melodic vocals, and for the first time, beautiful orchestral movements. These musical elements come together to introduce a new depth to the band’s music, while the album’s concept narrates the story of a world obsessed with relentless progression and the perils thereof, challenging listeners to think about their own place in the modern world.

Inspired by bands like Tool, Deftones and Gojira, Field of Giants has crafted an album that resonates with fans of progressive metal and alternative rock, but also appeals to listeners seeking something uniquely compelling. The album’s intricate composition and thematic depth are a testament to the band’s evolution, showcasing their ability to weave complex stories through heavy music.

The Distance Between Us All: The powerful opening track encapsulates the theme of the album, with a narrative that delves into the complexities of human connection, and the relentless pursuit of identity in an isolated world.

Through its poignant lyrics, the song explores the paradox of seeking unity in an era defined by division and individualism. The chorus, with its stark admonition to “Marry yourself if you find it so difficult to care for someone else” serves as a critical reflection on the self-centeredness that pervades modern life, suggesting that true fulfilment comes from bridging the ideological gaps that separate us.

Musically, “The Distance Between Us All” features Field of Giants’ signature blend of heavy guitars, dynamic drumming, and soaring vocals, enriched by a new layer of orchestral movements that underscore the song’s emotional depth.

Transform: The poignant second track, weaving a narrative of self-discovery, liberation, and living fully in the present. The song serves as a clarion call to listeners to not take time for granted, but instead, to free themselves from the constraints of passivity, and ignite the passions that lie within.

Musically, “Transform” combines heavy riffs with a melody that inspires the listener, perfectly complementing the song’s message of empowerment. The lyrics advocate for a transformation into a life that feels as exhilarating and momentous as a “feel good movie,” emphasizing the power of a fulfilling existence.

Say: Emerges as the introspective third track on Field of Giants’ album, delving into themes of existence and perception. The song portrays a deep introspection, questioning the impact of one’s presence through the metaphor of a message in a bottle adrift from everyone. Its haunting melody and reflective lyrics invite listeners to ponder the weight of words versus actions.

Musically, “Say” combines subtle instrumentation with a focus on atmospheric elements, allowing the poignant lyrics to take center stage. The song oscillates between calm verses and huge choruses to take listeners on an epic journey.

Nothing From You: Unfolds as the emotionally charged fourth track of the album, capturing the complexities of relationships, conflict and reconciliation. The song navigates through the dynamics of intimacy, and the desire to mend broken connections, encapsulated by the refrain, “I’m moulded from the pieces of you.”

Musically, “Nothing From You” balances between soft, introspective verses and powerful choruses, mirroring the tumultuous yet hopeful nature of repairing a relationship. The lyrics oscillate between vulnerability and strength, fear and courage, highlighting the transformative power of communication.

Into The Wild: The closing track of the album, serves as a powerful anthem for liberation and a return to authenticity. The song encapsulates a yearning to break free from societal constraints and rediscover a life of truth. Its lyrics champion the courage to leave behind the familiar and venture into the unknown.

As the finale of the album, “Into The Wild” leaves listeners with a resonant call to action: to embrace the adventure of existence, and find solace and vitality away from the trappings of modern life. It’s a fitting conclusion to an album that explores the distances and connections between all of us, ultimately advocating for a life filled with genuine experiences and relationships.

Field of Giants’ innovative approach to music and storytelling continues to garner acclaim, further establishing them within the metal and rock genres. “The Distance Between Us” marks a significant milestone in the band’s career.

To celebrate the album’s release, Field of Giants is also unveiling a series of visually captivating videos, beginning with “The Distance Between Us All” released earlier this month. These videos provide a visual representation of the album’s themes, enhancing the listener’s experience and immersion into the world Field of Giants has created.

“The Distance Between Us” is more than just an album; it’s an auditory journey that challenges listeners to reflect on the consequences of humanity’s relentless pursuit of progress. Field of Giants invites fans old and new to join them on this journey, promising an experience that is not only musically enriching but also thought-provoking.

Stream “The Distance Between Us” on Spotify, Apple Music, Amazon Music, Deezer, Bandcamp.

Follow Field of Giants on Facebook, Instagram, X, TikTok.

Media Contact
Company Name: Field of Giants Band
Contact Person: Martin Pidsley
Email: Send Email
Country: United Kingdom
Website: https://hypeddit.com/fieldofgiants

Effective SEO starts with good publicity, says 9-Figure Media

In this post, you will learn how effective SEO starts with good publicity. If you are looking for how to grow your business and gain good publicity, then read on to find out.

The most important thing is that when people search for your brand on Google, your brand shows up in a positive light, in a way that makes your prospective clients want to work with your brand.

But another important aspect of PR and publicity is its ability to rank high on the search engines for its targeted keywords or brand name. Search engines bring in the highest quality leads in customers. So, this makes it an effective way to bring in your best clients and customers through SEO.

Professionals at 9-Figure Media use SEO techniques to get the most out of every message they put out. They help clients increase visibility, create awareness, and differentiate their clients from their competitors.

In addition, effective SEO combined with good publicity greatly impacts the rankings of your business. When combined, SEO and PR bring in the right people to your website. And Google has a way to place your website at the top of the page, when your site generates backlinks from authority websites.

The more your site visits, the higher it moves until it reaches the first spot. This way, when people key in queries related to your industry, your site pops up first in the first page of Google. Moreover, this can help your website create the impression of credibility in the eyes of visitors and clients.

The public relations team at 9-Figure Media knows that to achieve great results for their clients, they need to follow SEO best practices. They deploy SEO strategy (it is the planning and implementation of steps to increase organic search engine rankings), which includes the following:

Research of trending keywords in their clients’ industry.
Combination of those trending keywords when writing press releases for their clients.
Linking your site in a natural way to avoid search engines seeing your site as ‘over-optimized’, and suspicious.
Breaking their clients’ content into readable sections and the insertion of relevant images, videos, and others.
Distribution of news articles to news outlets, and their publications, including authority sites, to generate back links to your site.

It is important to know that different content generates different buzz from different industries. 9-Figure Media analyzed that trending and evergreen industries like technology and finance generate more back links than the iron ore and coal mining industries.

When speaking on how effective SEO starts with good publicity, the CEO and Marketing Consultant of 9-Figure Media, Kennedy Cee, said, “The world we live in today is highly driven by queries of different people looking for solutions to their queries. And as a business looking to be right in front of those customers, you need to have their answers – detailed and ready. And to achieve the good publicity you desire for your business, you may need to incorporate effective SEO.”

“Most start-ups hardly find their footings with following SEO best practices, which hinder the visibility of their sites. The cyclic effects are low sales, and your customers seeking solutions from your competitors, whom they perceive as trustworthy. To avoid this, businesses need the services of a PR agency like 9 Figure Media to help them create SEO content”.

In conclusion, allowing a PR agency to incorporate SEO best practices into their PR strategies gives you an edge over your competitors, achieves better SEO ranking, and makes your clients perceive you as a credible source of the information they seek.

Media Contact
Company Name: 9-Figure Media Public Relations
Contact Person: Chris James
Email: Send Email
Phone: 9493426155
Address:1986 South Coast Highway
City: Laguna beach
State: CA
Country: United States
Website: https://9figuremedia.com

Bullous Pemphigoid Market to Exhibit Rapid Growth Rate During the Forecast Period (2023-2032), Investigates DelveInsight | AstraZeneca, AKARI Therapeutics, Regeneron Pharma, Argenx

The Bullous Pemphigoid market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Bullous Pemphigoid pipeline products will significantly revolutionize the Bullous Pemphigoid market dynamics.

DelveInsight’s “Bullous Pemphigoid Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Bullous Pemphigoid, historical and forecasted epidemiology as well as the Bullous Pemphigoid market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

The Bullous Pemphigoid market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.

To Know in detail about the Bullous Pemphigoid market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Bullous Pemphigoid Market Insights

Bullous Pemphigoid Overview

As per national organization of rare diseases (NORD), bullous pemphigoid (BP) is a rare, autoimmune, chronic skin disorder characterized by blistering, urticarial lesions (hives) and itching. Less commonly these blisters can involve the mucous membranes including the eyes, oral mucosa, oesophagus and genital mucosa. Moreover, it is the most common autoimmune subepidermal blistering disorder, representing 80% of subepidermal immunobullous cases.

BD most commonly affects elderly patients between the ages of 60 to 80 years. It ranges from mildly itchy welts to severe blisters and infection, and may affect a small area of the body or be widespread. It is caused by autoantibodies directed against the hemidesmosomal proteins BP180 and BP230.

Some of the key facts of the Bullous Pemphigoid Market Report:

The Bullous Pemphigoid market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
According to Baigrie and Nookala, BP affects individuals older than 60 years of age. The annual incidence is 6 to 13 new cases per million people in the United States, while it affects 12 to 13 per million in Central Europe. It has an equal incidence in both males and females and has no racial bias
As per Kridin and Ludwig (2018), based on health insurance data, the prevalence of BP has been estimated at 259 per million population in Germany, i.e., ~21,000 patients with BP lived in Germany
Key Bullous Pemphigoid Companies: AstraZeneca, AKARI Therapeutics, Regeneron Pharmaceuticals, Argenx, and others
Key Bullous Pemphigoid Therapies: Benralizumab, Nomacopan, Dupilumab, Efgartigimod, and others
The Bullous Pemphigoid epidemiology based on age-specific cases analyzed that Bullous Pemphigoid is more prevalent in older age group (66 to 83 years)

Get a Free sample for the Bullous Pemphigoid Market Report –

https://www.delveinsight.com/sample-request/bullous-pemphigoid-market

Key benefits of the Bullous Pemphigoid Market report:

Bullous Pemphigoid market report covers a descriptive overview and comprehensive insight of the Bullous Pemphigoid Epidemiology and Bullous Pemphigoid market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
The Bullous Pemphigoid market report provides insights on the current and emerging therapies.
Bullous Pemphigoid market report provides a global historical and forecasted market covering drug outreach in 7MM.
The Bullous Pemphigoid market report offers an edge that will help develop business strategies by understanding trends shaping and driving the Bullous Pemphigoid market.

Download the report to understand which factors are driving Bullous Pemphigoid epidemiology trends @ Bullous Pemphigoid Epidemiological Insights

Bullous Pemphigoid Market

The dynamics of the Bullous Pemphigoid market are anticipated to change in the coming years owing to the expected launch of emerging therapies and others during the forecasted period 2019-2032.

Bullous Pemphigoid Epidemiology

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Bullous Pemphigoid Epidemiology Segmentation:

The Bullous Pemphigoid market report proffers epidemiological analysis for the study period 2019–2032 in the 7MM segmented into:

Total Prevalence of Bullous Pemphigoid
Prevalent Cases of Bullous Pemphigoid by severity
Gender-specific Prevalence of Bullous Pemphigoid
Diagnosed Cases of Episodic and Chronic Bullous Pemphigoid

Bullous Pemphigoid Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Bullous Pemphigoid market or expected to get launched during the study period. The analysis covers Bullous Pemphigoid market uptake by drugs, patient uptake by therapies, and sales of each drug.

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Bullous Pemphigoid Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

To know more about Bullous Pemphigoid treatment, visit @ Bullous Pemphigoid Medications

Bullous Pemphigoid Therapies and Key Companies

Benralizumab: AstraZeneca
Nomacopan: AKARI Therapeutics
Dupilumab: Regeneron Pharmaceuticals
Efgartigimod: Argenx

Bullous Pemphigoid Market Strengths

Important progress has been made regarding understanding disease pathology, diagnosis, and treatment effects in Bullous Pemphigoid.
Population rates of social anxiety disorder in children and young people have been investigated in several countries.
Many therapies are under investigation in various phases of clinical trials.

Scope of the Bullous Pemphigoid Market Report

Study Period: 2019–2032
Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
Key Bullous Pemphigoid Companies: AstraZeneca, AKARI Therapeutics, Regeneron Pharmaceuticals, Argenx, and others
Key Bullous Pemphigoid Therapies: Benralizumab, Nomacopan, Dupilumab, Efgartigimod, and others
Bullous Pemphigoid Therapeutic Assessment: Bullous Pemphigoid current marketed and Bullous Pemphigoid emerging therapies
Bullous Pemphigoid Market Dynamics: Bullous Pemphigoid market drivers and Bullous Pemphigoid market barriers
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
Bullous Pemphigoid Unmet Needs, KOL’s views, Analyst’s views, Bullous Pemphigoid Market Access and Reimbursement

Bullous Pemphigoid Market Unmet Needs

Challenge in recognition of condition
Development of novel therapies
Limited availability in services
Poor disease understanding
Development of effective treatment

Table of Contents

1. Bullous Pemphigoid Market Report Introduction

2. Executive Summary for Bullous Pemphigoid

3. SWOT analysis of Bullous Pemphigoid

4. Bullous Pemphigoid Patient Share (%) Overview at a Glance

5. Bullous Pemphigoid Market Overview at a Glance

6. Bullous Pemphigoid Disease Background and Overview

7. Bullous Pemphigoid Epidemiology and Patient Population

8. Country-Specific Patient Population of Bullous Pemphigoid

9. Bullous Pemphigoid Current Treatment and Medical Practices

10. Bullous Pemphigoid Unmet Needs

11. Bullous Pemphigoid Emerging Therapies

12. Bullous Pemphigoid Market Outlook

13. Country-Wise Bullous Pemphigoid Market Analysis (2019–2032)

14. Bullous Pemphigoid Market Access and Reimbursement of Therapies

15. Bullous Pemphigoid Market Drivers

16. Bullous Pemphigoid Market Barriers

17. Bullous Pemphigoid Appendix

18. Bullous Pemphigoid Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

About DelveInsight

DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight
Contact Person: Gaurav Bora
Email: Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Bullous Pemphigoid Market to Exhibit Rapid Growth Rate During the Forecast Period (2023-2032), Investigates DelveInsight | AstraZeneca, AKARI Therapeutics, Regeneron Pharma, Argenx

Diffuse Cutaneous Systemic Sclerosis Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2023-2032), States DelveInsight | Kyowa Hakko Kirin, Kadmon Corporation, Sanofi

The Diffuse Cutaneous Systemic Sclerosis market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Diffuse Cutaneous Systemic Sclerosis pipeline products will significantly revolutionize the Diffuse Cutaneous Systemic Sclerosis market dynamics.

DelveInsight’s “Diffuse Cutaneous Systemic Sclerosis Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Diffuse Cutaneous Systemic Sclerosis, historical and forecasted epidemiology as well as the Diffuse Cutaneous Systemic Sclerosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

The Diffuse Cutaneous Systemic Sclerosis market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.

To Know in detail about the Diffuse Cutaneous Systemic Sclerosis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Diffuse Cutaneous Systemic Sclerosis Market Insights

Diffuse Cutaneous Systemic Sclerosis Overview

Systemic sclerosis (SSc) (systemic scleroderma) is a chronic connective tissue disease of unknown etiology that causes widespread microvascular damage and excessive deposition of collagen in the skin and internal organs. There are two types of Systemic sclerosis: Limited cutaneous scleroderma (lcSSc) and Diffuse cutaneous systemic sclerosis (dcSSc).

Some of the key facts of the Diffuse Cutaneous Systemic Sclerosis Market Report:

The Diffuse Cutaneous Systemic Sclerosis market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
According to a study by Khanna et al., the prevalence of SSc varies widely both within and between countries, affecting an estimated 240 people per million in the United States and 35 per million in the United Kingdom and Japan
According to Orphanet the prevalence of Diffuse cutaneous systemic sclerosis is estimated at about 1/25,000 adults and women are predominantly affected F/M sex ratio around 4:1.
Key Diffuse Cutaneous Systemic Sclerosis Companies: Kyowa Hakko Kirin, Kadmon Corporation, Sanofi, Emerald Health Pharmaceuticals, Mitsubishi Tanabe Pharma, Horizon Therapeutics, Gesynta Pharma, and others
Key Diffuse Cutaneous Systemic Sclerosis Therapies: Brodalumab, Belumosudil, EHP-101, MT-7117, HZN-825, GS-248, and others
The Diffuse Cutaneous Systemic Sclerosis epidemiology based on gender analyzed that females are more affected with Diffuse cutaneous systemic sclerosis than males

Get a Free sample for the Diffuse Cutaneous Systemic Sclerosis Market Report:

https://www.delveinsight.com/report-store/diffuse-cutaneous-systemic-sclerosis-dcssc-market

Key benefits of the Diffuse Cutaneous Systemic Sclerosis Market report:

Diffuse Cutaneous Systemic Sclerosis market report covers a descriptive overview and comprehensive insight of the Diffuse Cutaneous Systemic Sclerosis Epidemiology and Diffuse Cutaneous Systemic Sclerosis market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
The Diffuse Cutaneous Systemic Sclerosis market report provides insights on the current and emerging therapies.
Diffuse Cutaneous Systemic Sclerosis market report provides a global historical and forecasted market covering drug outreach in 7MM.
The Diffuse Cutaneous Systemic Sclerosis market report offers an edge that will help develop business strategies by understanding trends shaping and driving the Diffuse Cutaneous Systemic Sclerosis market.

Download the report to understand which factors are driving Diffuse Cutaneous Systemic Sclerosis epidemiology trends @ Diffuse Cutaneous Systemic Sclerosis Epidemiological Insights

Diffuse Cutaneous Systemic Sclerosis Market

The dynamics of the Diffuse Cutaneous Systemic Sclerosis market are anticipated to change in the coming years owing to the expected launch of emerging therapies and others during the forecasted period 2019-2032.

Diffuse Cutaneous Systemic Sclerosis Epidemiology

Diffuse Cutaneous Systemic Sclerosis Epidemiology Segmentation:

The Diffuse Cutaneous Systemic Sclerosis market report proffers epidemiological analysis for the study period 2019–2032 in the 7MM segmented into:

Total Prevalence of Diffuse Cutaneous Systemic Sclerosis
Prevalent Cases of Diffuse Cutaneous Systemic Sclerosis by severity
Gender-specific Prevalence of Diffuse Cutaneous Systemic Sclerosis
Diagnosed Cases of Episodic and Chronic Diffuse Cutaneous Systemic Sclerosis

Diffuse Cutaneous Systemic Sclerosis Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Diffuse Cutaneous Systemic Sclerosis market or expected to get launched during the study period. The analysis covers Diffuse Cutaneous Systemic Sclerosis market uptake by drugs, patient uptake by therapies, and sales of each drug.

The report also covers the Diffuse Cutaneous Systemic Sclerosis Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

To know more about Diffuse Cutaneous Systemic Sclerosis treatment, visit @ Diffuse Cutaneous Systemic Sclerosis Medications

Diffuse Cutaneous Systemic Sclerosis Therapies and Key Companies

Brodalumab: Kyowa Hakko Kirin
Belumosudil: Kadmon Corporation /Sanofi
EHP-101: Emerald Health Pharmaceuticals
MT-7117: Mitsubishi Tanabe Pharma
HZN-825: Horizon Therapeutics
GS-248: Gesynta Pharma

Diffuse Cutaneous Systemic Sclerosis Market Unmet Needs

Challenges in diagnoses
Development of novel therapies
Limitations in gene therapy
Poor disease understanding
Clinical biomarkers

Diffuse Cutaneous Systemic Sclerosis Market Drivers

Intravenous immunoglobulin, anti-TNF-α and anti-IL-17 biologics as well as other repurposed biologics such as IL-12/IL-23 and IL-4Rα neutralizing antibodies have brought clinical benefit in case studies.
Establishment of National Registry for Ichthyosis to promote the search for basic defects, improve methods of diagnosis, and develop effective methods of treatment and/or prevention.

Scope of the Diffuse Cutaneous Systemic Sclerosis Market Report

Study Period: 2019–2032
Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
Key Diffuse Cutaneous Systemic Sclerosis Companies: Kyowa Hakko Kirin, Kadmon Corporation, Sanofi, Emerald Health Pharmaceuticals, Mitsubishi Tanabe Pharma, Horizon Therapeutics, Gesynta Pharma, and others
Key Diffuse Cutaneous Systemic Sclerosis Therapies: Brodalumab, Belumosudil, EHP-101, MT-7117, HZN-825, GS-248, and others
Diffuse Cutaneous Systemic Sclerosis Therapeutic Assessment: Diffuse Cutaneous Systemic Sclerosis current marketed and Diffuse Cutaneous Systemic Sclerosis emerging therapies
Diffuse Cutaneous Systemic Sclerosis Market Dynamics: Diffuse Cutaneous Systemic Sclerosis market drivers and Diffuse Cutaneous Systemic Sclerosis market barriers
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
Diffuse Cutaneous Systemic Sclerosis Unmet Needs, KOL’s views, Analyst’s views, Diffuse Cutaneous Systemic Sclerosis Market Access and Reimbursement

Discover more about therapies set to grab major Diffuse Cutaneous Systemic Sclerosis market share @ Diffuse Cutaneous Systemic Sclerosis market forecast

Table of Contents

1. Diffuse Cutaneous Systemic Sclerosis Market Report Introduction

2. Executive Summary for Diffuse Cutaneous Systemic Sclerosis

3. SWOT analysis of Diffuse Cutaneous Systemic Sclerosis

4. Diffuse Cutaneous Systemic Sclerosis Patient Share (%) Overview at a Glance

5. Diffuse Cutaneous Systemic Sclerosis Market Overview at a Glance

6. Diffuse Cutaneous Systemic Sclerosis Disease Background and Overview

7. Diffuse Cutaneous Systemic Sclerosis Epidemiology and Patient Population

8. Country-Specific Patient Population of Diffuse Cutaneous Systemic Sclerosis

9. Diffuse Cutaneous Systemic Sclerosis Current Treatment and Medical Practices

10. Diffuse Cutaneous Systemic Sclerosis Unmet Needs

11. Diffuse Cutaneous Systemic Sclerosis Emerging Therapies

12. Diffuse Cutaneous Systemic Sclerosis Market Outlook

13. Country-Wise Diffuse Cutaneous Systemic Sclerosis Market Analysis (2019–2032)

14. Diffuse Cutaneous Systemic Sclerosis Market Access and Reimbursement of Therapies

15. Diffuse Cutaneous Systemic Sclerosis Market Drivers

16. Diffuse Cutaneous Systemic Sclerosis Market Barriers

17. Diffuse Cutaneous Systemic Sclerosis Appendix

18. Diffuse Cutaneous Systemic Sclerosis Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

About DelveInsight

It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Diffuse Cutaneous Systemic Sclerosis Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2023-2032), States DelveInsight | Kyowa Hakko Kirin, Kadmon Corporation, Sanofi

Hangshot Unveils Groundbreaking Solution for Post-Drinking Wellness

Hangshot is a company that focuses on wellness solutions specifically designed to address the after-effects of alcohol consumption. Their product is crafted to support hydration, metabolism, and overall well-being, catering to those who seek a more balanced lifestyle while enjoying social activities. Hangshot emphasizes scientific research and natural ingredients in their formula, offering a vegan and non-GMO product.

Bangkok, Thailand – According to research, approximately 75% of people who consume alcohol in large quantities experience hangover symptoms the following day. In response to this widespread issue, Hangshot has introduced an innovative product designed to support the body’s recovery process after alcohol consumption – the Orange Flavor 30ml Shot.

The company’s focus is on enhancing post-drinking wellness through a scientifically formulated shot, aiming to address common hangover symptoms. They claim their approach is rooted in providing a solution supporting hydration, metabolic processes, and overall well-being. This will mitigate the undesirable effects experienced by many the day after drinking.

“Our Orange Flavor 30ml Shot transcends the mere alleviation of morning-after hangover symptoms,” says Hangshot’s CEO, Hasavee Wirunsiripak. “It’s rich in antioxidants, vitamins, and minerals that work together to boost the body’s natural detoxification process and replenish essential nutrients lost during alcohol consumption,” he adds.

This initiative reflects a growing trend towards prioritizing health and wellness within the context of social and recreational alcohol consumption. As public awareness of the importance of post-drinking recovery continues to rise, Hangshot’s proactive approach could set new industry standards, emphasizing the company’s role at the forefront of innovative health solutions.

About Hangshot:

Hangshot is a brand that enhances post-drinking wellness with its scientifically formulated 30ml wellness shot. Developed through extensive research and testing, their product aims to address the root causes of hangovers using premium botanical extracts and research-backed ingredients.

The brand prioritizes natural, vegan, and non-GMO components, adhering to GMP manufacturing standards to ensure high-quality production. Their mission revolves around improving next-day energy and well-being and encouraging responsible drinking practices among consumers.

Media Contact
Company Name: Hangshot
Contact Person: Hasavee Wirunsiripak
Email: Send Email
Country: Thailand
Website: https://us.hangshot.co/

EpicPaint Redefines the Art Experience with Revolutionary Innovative Features

EpicPaint is a pioneering platform dedicated to transforming cherished memories into timeless masterpieces. With a fusion of cutting-edge technology and the skilled craftsmanship of professional artists, EpicPaint redefines the online painting experience, making art accessible and personalized for everyone.

Delaware, United States – EpicPaint, a leading innovator in the realm of art, has unveiled groundbreaking features aimed at revolutionizing the online painting experience. Through its new platform, EpicPaint transcends the boundaries of conventional digital imaging, empowering users to transform their cherished memories into captivating works of art.

In a world saturated with mundane photo prints, EpicPaint emerges as a beacon of creativity, offering users the opportunity to immortalize their most treasured moments in a unique and personalized manner. Unlike conventional photo printing services, EpicPaint’s platform transcends mere replication, breathing life into digital images and infusing them with the vibrancy and depth of professional artwork.

What sets EpicPaint apart is its commitment to craftsmanship. While other online painting services rely on automated algorithms, EpicPaint boasts a team of seasoned artists dedicated to meticulously handcrafting each digital portrait. This human touch ensures that every creation is imbued with authenticity and emotion, elevating the final product to the realm of true artistry.

With an array of customization options at their fingertips, users exercise complete control over the aesthetic of their digital paintings. “From selecting canvas size and frame style to fine-tuning colors and applying filters, the possibilities are as limitless as the imagination,” says EpicPaint spokesperson.

EpicPaint’s user-friendly interface and advanced technology streamline the creative process, enabling users to seamlessly transform their favorite photos into stunning paintings in just a few simple steps:

Upload photos and select preferred style.
Preview and approve the artwork or request unlimited revisions.
Receive meticulously crafted portraits delivered to their doorstep.

About EpicPaint:

EpicPaint’s goal is to make art a tangible and meaningful part of everyday life. They use technology and human creativity to help people turn memories into lasting and emotional pieces of art.

See how their process works here: https://epicpaint.com/pages/how-it-works

Media Contact
Company Name: EpicPaint
Contact Person: Mike Green
Email: Send Email
Country: United States
Website: https://epicpaint.com/

Diffuse Intrinsic Pontine Glioma Market Report 2032: Epidemiology Data, Pipeline Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight | Chimerix, SonaALAsense, Bexion Pharma, Kazia Therapeutics

The Diffuse Intrinsic Pontine Glioma market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Diffuse Intrinsic Pontine Glioma pipeline products will significantly revolutionize the Diffuse Intrinsic Pontine Glioma market dynamics.

DelveInsight’s “Diffuse Intrinsic Pontine Glioma Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Diffuse Intrinsic Pontine Glioma, historical and forecasted epidemiology as well as the Diffuse Intrinsic Pontine Glioma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

The Diffuse Intrinsic Pontine Glioma market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.

To Know in detail about the Diffuse Intrinsic Pontine Glioma market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Diffuse Intrinsic Pontine Glioma Market Insights

Diffuse Intrinsic Pontine Glioma Overview

According to the National Cancer Institute (NCI), Diffuse Intrinsic Pontine Glioma (DIPG: also known as Diffuse Midline Glioma (DMG)) are primary central nervous system (CNS) tumors.

DIPG is highly-aggressive and difficult-to-treat brain tumors found at the base of the brain. They are glial tumors which means they arise from the brain’s glial tissue that help support and protect the brain’s neurons. These tumors are found in an area of the brainstem called the pons, which controls many of the body’s most vital functions such as breathing, blood pressure and heart rate.

Some of the key facts of the Diffuse Intrinsic Pontine Glioma Market Report:

The Diffuse Intrinsic Pontine Glioma market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
H3 K27 mutations, most commonly in H3F3A, are common in Diffuse Intrinsic Pontine Glioma (DIPG). The exact frequency of these mutations in adults with gliomas in the midline location is unknown
As per a study by Himes et al. titled, “Treatment Strategies in Diffuse Midline Gliomas With the H3K27M Mutation: The Role of Convection-Enhanced Delivery in Overcoming Anatomic Challenges”, primary pediatric brain tumors are rare entities, with an incidence of around 2,200 cases annually
As per the World Health Organization (WHO), High-grade glioma (HGG) consists of three types of brain tumor such as Anaplastic Astocytoma (Grade III), Glioblastoma (Grade IV) and Diffuse Intrinsic Pontine Glioma (DIPG) (Grade IV)
Key Diffuse Intrinsic Pontine Glioma Companies: Chimerix, SonaALAsense, Bexion Pharmaceuticals, Kazia Therapeutics, and others
Key Diffuse Intrinsic Pontine Glioma Therapies: ONC201, SDT-201, BXQ-350, Paxalisib, and others

Get a Free sample for the Diffuse Intrinsic Pontine Glioma Market Report –

https://www.delveinsight.com/sample-request/diffuse-intrinsic-pontine-glioma-dipg-market

Key benefits of the Diffuse Intrinsic Pontine Glioma Market report:

Diffuse Intrinsic Pontine Glioma market report covers a descriptive overview and comprehensive insight of the Diffuse Intrinsic Pontine Glioma Epidemiology and Diffuse Intrinsic Pontine Glioma market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
The Diffuse Intrinsic Pontine Glioma market report provides insights on the current and emerging therapies.
Diffuse Intrinsic Pontine Glioma market report provides a global historical and forecasted market covering drug outreach in 7MM.
The Diffuse Intrinsic Pontine Glioma market report offers an edge that will help develop business strategies by understanding trends shaping and driving the Diffuse Intrinsic Pontine Glioma market.

Download the report to understand which factors are driving Diffuse Intrinsic Pontine Glioma epidemiology trends @ Diffuse Intrinsic Pontine Glioma Epidemiological Insights

Diffuse Intrinsic Pontine Glioma Market

The dynamics of the Diffuse Intrinsic Pontine Glioma market are anticipated to change in the coming years owing to the expected launch of emerging therapies and others during the forecasted period 2019-2032.

Diffuse Intrinsic Pontine Glioma Epidemiology

Diffuse Intrinsic Pontine Glioma Epidemiology Segmentation:

The Diffuse Intrinsic Pontine Glioma market report proffers epidemiological analysis for the study period 2019–2032 in the 7MM segmented into:

Total Prevalence of Diffuse Intrinsic Pontine Glioma
Prevalent Cases of Diffuse Intrinsic Pontine Glioma by severity
Gender-specific Prevalence of Diffuse Intrinsic Pontine Glioma
Diagnosed Cases of Episodic and Chronic Diffuse Intrinsic Pontine Glioma

Diffuse Intrinsic Pontine Glioma Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Diffuse Intrinsic Pontine Glioma market or expected to get launched during the study period. The analysis covers Diffuse Intrinsic Pontine Glioma market uptake by drugs, patient uptake by therapies, and sales of each drug.

The report also covers the Diffuse Intrinsic Pontine Glioma Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

To know more about Diffuse Intrinsic Pontine Glioma treatment, visit @ Diffuse Intrinsic Pontine Glioma Medications

Diffuse Intrinsic Pontine Glioma Therapies and Key Companies

ONC201: Chimerix
SDT-201: SonaALAsense
BXQ-350: Bexion Pharmaceuticals
Paxalisib: Kazia Therapeutics

Diffuse Intrinsic Pontine Glioma Market Drivers

Diffuse Intrinsic Pontine Glioma market has diverse pipeline
Pipeline therapies are coming with novel mechanism of action
Certain pipeline therapies have already been awarded with drug designations such as orphan drug designation, Fast Track designation by the FDA and EMA.

Scope of the Diffuse Intrinsic Pontine Glioma Market Report

Study Period: 2019–2032
Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
Key Diffuse Intrinsic Pontine Glioma Companies: Chimerix, SonaALAsense, Bexion Pharmaceuticals, Kazia Therapeutics, and others
Key Diffuse Intrinsic Pontine Glioma Therapies: ONC201, SDT-201, BXQ-350, Paxalisib, and others
Diffuse Intrinsic Pontine Glioma Therapeutic Assessment: Diffuse Intrinsic Pontine Glioma current marketed and Diffuse Intrinsic Pontine Glioma emerging therapies
Diffuse Intrinsic Pontine Glioma Market Dynamics: Diffuse Intrinsic Pontine Glioma market drivers and Diffuse Intrinsic Pontine Glioma market barriers
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
Diffuse Intrinsic Pontine Glioma Unmet Needs, KOL’s views, Analyst’s views, Diffuse Intrinsic Pontine Glioma Market Access and Reimbursement

Diffuse Intrinsic Pontine Glioma Market Barriers

Use of extensive bioinformatics can help in the robust research and development of Diffuse Intrinsic Pontine Glioma
Diffuse Intrinsic Pontine Glioma disease progression present an exciting opportunity to improve treatment landscape of this devastating disease

Table of Contents

1. Diffuse Intrinsic Pontine Glioma Market Report Introduction

2. Executive Summary for Diffuse Intrinsic Pontine Glioma

3. SWOT analysis of Diffuse Intrinsic Pontine Glioma

4. Diffuse Intrinsic Pontine Glioma Patient Share (%) Overview at a Glance

5. Diffuse Intrinsic Pontine Glioma Market Overview at a Glance

6. Diffuse Intrinsic Pontine Glioma Disease Background and Overview

7. Diffuse Intrinsic Pontine Glioma Epidemiology and Patient Population

8. Country-Specific Patient Population of Diffuse Intrinsic Pontine Glioma

9. Diffuse Intrinsic Pontine Glioma Current Treatment and Medical Practices

10. Diffuse Intrinsic Pontine Glioma Unmet Needs

11. Diffuse Intrinsic Pontine Glioma Emerging Therapies

12. Diffuse Intrinsic Pontine Glioma Market Outlook

13. Country-Wise Diffuse Intrinsic Pontine Glioma Market Analysis (2019–2032)

14. Diffuse Intrinsic Pontine Glioma Market Access and Reimbursement of Therapies

15. Diffuse Intrinsic Pontine Glioma Market Drivers

16. Diffuse Intrinsic Pontine Glioma Market Barriers

17. Diffuse Intrinsic Pontine Glioma Appendix

18. Diffuse Intrinsic Pontine Glioma Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

About DelveInsight

It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Diffuse Intrinsic Pontine Glioma Market Report 2032: Epidemiology Data, Pipeline Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight | Chimerix, SonaALAsense, Bexion Pharma, Kazia Therapeutics

Revolutionizing Home Comfort: Leka Systems Leads the Way with Thermally Efficient Solutions

Leka Systems is reshaping the landscape of residential living, one installation at a time.

In the realm of home improvement, where comfort meets innovation, Leka Systems stands as a beacon of excellence. With a steadfast commitment to engineering thermally efficient, engineered products, Leka Systems is reshaping the landscape of residential living, one installation at a time.

Video Link: https://www.youtube.com/embed/pcVRL86x1ts

Gone are the days of compromising comfort for aesthetics. Leka Systems has ushered in a new era of home improvement, where homeowners no longer have to choose between style and functionality. By leveraging cutting-edge technology and innovative composite materials, Leka Systems has developed a range of products that not only enhance the visual appeal of homes but also optimize energy efficiency and comfort.

At the heart of Leka Systems’ success lies its unwavering dedication to engineering excellence. Unlike traditional roofing materials that are prone to deterioration and thermal inefficiency, Leka Systems’ products are meticulously crafted to withstand the test of time. By utilizing advanced composite materials that are lightweight, durable, and impervious to moisture, Leka Systems ensures that homes remain comfortable and energy-efficient for decades to come.

What sets Leka Systems apart is its relentless pursuit of perfection and commitment to customer satisfaction. Each product is meticulously designed and rigorously tested to meet the highest standards of quality and performance. Whether it’s a Tiled Warm Conservatory Roof system or a Modular Home Extension, homeowners can trust Leka Systems to deliver solutions that exceed their expectations.

In an era where sustainability is paramount, Leka Systems takes pride in offering environmentally friendly alternatives to traditional construction materials. By reducing energy consumption and minimizing waste, Leka Systems not only helps homeowners save money on utility bills but also contributes to a greener, more sustainable future.

At its core, Leka Systems is driven by a desire to empower homeowners to create spaces that reflect their unique lifestyle and preferences. Whether it’s transforming a conservatory into a year-round living space or expanding living areas with a modular home extension, Leka Systems’ products are designed to enhance the functionality and comfort of homes, allowing homeowners to enjoy their living spaces to the fullest.

As Leka Systems continues to push the boundaries of innovation and sustainability, the future looks brighter than ever. With a steadfast commitment to excellence and a passion for improving the lives of homeowners, Leka Systems is poised to lead the way in revolutionizing the residential construction industry.

For homeowners seeking to elevate their living spaces and embrace a more comfortable, energy-efficient lifestyle, Leka Systems offers a solution. With its range of thermally efficient, engineered products, Leka Systems is leading the charge towards a brighter, more sustainable future for residential living. Join the revolution today and experience the Leka advantage for yourself.

Media Contact
Company Name: TMSP Agency
Contact Person: Mark Stephen Pooler
Email: Send Email
Phone: +447930691683
Country: United Kingdom
Website: https://contactmark.me